Benitec Biopharma Inc - Company Profile

Powered by

All the data and insights you need on Benitec Biopharma Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Benitec Biopharma Inc Strategy Report

  • Understand Benitec Biopharma Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Benitec Biopharma Inc: Overview

Select Item

Benitec Biopharma Inc (Benitec) is a clinical stage biotechnology company. It develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. The company’s pipeline products include BB-301 for oculopharyngeal muscular dystrophy (OPMD) and BB-103 for the treatment of hepatitis B. It also licenses ddRNAi to various biopharmaceutical companies for the development of drugs. Benitec is headquartered in Hayward, California, the US

 Gain a 360-degree view of Benitec Biopharma Inc and make more informed decisions for your business Gain a 360-degree view of Benitec Biopharma Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 3940 Trust Way, Hayward, California, 94545
Website benitec.com
Telephone 1 510 7800819
No of Employees 18
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange BNTC (NASD)
Revenue (2022) $75,000 2.7% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -7.4% (2022 vs 2021)
Market Cap* $17.7M
Net Profit Margin (2022) XYZ -4.6% (2022 vs 2021)
* As of and is in US$
View Benitec Biopharma Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Benitec Biopharma Inc premium industry data and analytics

20+

Pipeline Drugs

Identify which of Benitec Biopharma Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

12+

Clinical Trials

Determine Benitec Biopharma Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Benitec Biopharma Inc’s relevant decision makers and contact details.

7

Catalyst Calendar

Proactively evaluate Benitec Biopharma Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline
BB- 301:
Oculopharyngeal Muscular Dystrophy
XYZ
XYZ
XYZ
Understand Benitec Biopharma Inc portfolio and identify potential areas for collaboration Understand Benitec Biopharma Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Benitec Biopharma Inc Alnylam Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Silence Therapeutics Plc Arbutus Biopharma Corp
Headquarters United States of America United States of America United States of America United Kingdom United States of America
City Hayward Cambridge Pasadena London Warminster
State/Province California Massachusetts California England Pennsylvania
No. of Employees 18 2,100 525 116 73
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Jerel Banks Chairman; Chief Executive Officer Executive Board 2018 48
Edward Smith Director Non Executive Board 2020 52
J. Kevin Buchi Director Non Executive Board 2013 68
Megan Boston Director - Executive Non Executive Board 2018 51
Peter Francis Director Non Executive Board 2006 67
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Benitec Biopharma Inc key executives to enhance your sales strategy Gain insight into Benitec Biopharma Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward